| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | (0.1) | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 2.5 | 3.1 | 6.4 | 7.3 | 5.7 | 6.2 | 5.1 | −18.6% | |
| Selling, general & administrative | 0.4 | 2.5 | 7.0 | 4.8 | 4.2 | 4.9 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 2.9 | 5.6 | 13.5 | 12.0 | 9.9 | 11.1 | 9.3 | −16.5% | |
| Operating income | (2.9) | (5.6) | (13.6) | (12.0) | (9.9) | (11.1) | (9.3) | +16.5% | |
| Interest expense | 0.0 | 1.2 | 0.0 | 0.6 | 0.3 | 0.0 | — | — | |
| Interest income | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 2.2 | +16615.4% | |
| Other income / expense | 0.1 | 1.5 | 1.2 | 1.9 | (0.3) | (0.0) | — | — | |
| Pre-tax income | (2.8) | (4.0) | (12.3) | (10.1) | (10.2) | (11.1) | (7.2) | +35.6% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (2.8) | (4.0) | (12.3) | (10.1) | (10.2) | (11.1) | (7.2) | +35.6% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (0.51) | (0.23) | (1.07) | (0.83) | (0.55) | (0.44) | (4.76) | −982.2% | |
| EPS, diluted (per share) | (0.51) | (0.23) | (1.07) | (0.83) | (0.55) | (0.44) | (4.76) | −982.2% | |
| EBITDA | (2.8) | (2.9) | (12.2) | (9.6) | (9.9) | (11.1) | — | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | — | — | |
| Weighted average shares (shares) | 5,519,000 | 10,856,000 | 11,505,000 | 13,640,000 | 18,602,000 | 25,481,343 | — | — | |
| Weighted average diluted shares (shares) | 5,519,000 | 10,856,000 | 11,505,000 | 13,640,000 | 18,602,000 | 25,481,343 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2025-03-31 and uses four consecutive reported quarters.
